Mingchen HealthLtd Valuation

Q: What is the Fair Price of 002919 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

002919 (CN¥15.56) is trading above our estimate of [[fair value]] (CN¥6.73)

Is 002919 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002919 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002919 (CN¥15.56) is trading above our estimate of fair value (CN¥6.73)

Significantly Below Fair Value: 002919 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002919?

Key metric: As 002919 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 002919. This is calculated by dividing 002919's market cap by their current revenue.
What is 002919's PS Ratio?
PS Ratio	3.1x
Sales	CN¥1.32b
Market Cap	CN¥4.14b

002919 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3x
Enterprise Value/EBITDA	15.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 002919's PS Ratio compare to its peers?

The above table shows the PS ratio for 002919 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	4.6x
300791 Sirio Pharma	1.5x	14.4%	CN¥6.3b
600249 Liuzhou Liangmianzhen	3x	n/a	CN¥3.3b
301507 Hangzhou Minsheng Healthcare	7.8x	n/a	CN¥4.8b
603896 Zhejiang Shouxiangu Pharmaceutical	6.1x	16.1%	CN¥4.3b
002919 Mingchen HealthLtd	3.1x	n/a	CN¥4.1b

Price-To-Sales vs Peers: 002919 is good value based on its Price-To-Sales Ratio (3.1x) compared to the peer average (4.6x).

Price to Sales Ratio vs Industry

How does 002919's PS Ratio compare vs other companies in the CN Personal Products Industry?

0 Companies	Price / Sales	Estimated Growth	Market Cap

No more companies available in this PS range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 002919 is good value based on its Price-To-Sales Ratio (3.1x) compared to the CN Personal Products industry average (3.3x).

Price to Sales Ratio vs Fair Ratio

What is 002919's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002919 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 002919's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Sirio Pharma

CN¥6.3b

Operates as a contract manufacturer for dietary supplement industry worldwide.

300791

CN¥26.94

-0.7%

-0.3%

SYoung Group

CN¥4.9b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.74

-0.9%

-22.3%